Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
Meng Zhang(Capital Medical University), Mingfeng Zhao(Nankai University), Wenyi Lu(Tianjin First Center Hospital), Cuicui Lyu(Tianjin First Center Hospital), Xiaomei Zhang(Qilu Hospital of Shandong University), Xinping Cao(Tianjin Medical University), Hairong Lyu(University of Bristol), Jiaxi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xia Xiao(Hebei Medical University), Xiaoyuan He(Nankai University), Juanxia Meng(Nankai University), Yedi Pu(Tianjin First Center Hospital)
Cited by 12
Related Papers
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
|Cell Death and Disease|2013|129
Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021
|EClinicalMedicine|2024|93
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
|Frontiers in Oncology|2020|82